Efficacy and safety of novel non-steroidal mineralocorticoid receptor antagonist finerenone in the management of diabetic kidney disease: A meta-analysis

Efficacy and safety of novel non-steroidal mineralocorticoid receptor antagonist finerenone in the management of diabetic kidney disease: A meta-analysis

Background: Data are scant on use of finerenone in diabetic kidney disease (DKD). We undertook this meta-analysis to address this knowledge gap. Methods: Electronic databases were searched for randomized controlled trials (RCTs) involving diabetes patients receiving finerenone compared to controls....

Full description

Bibliographic Details
Main Authors: Deep Dutta, Vineet Surana, Saptarshi Bhattacharya, Sameer Aggarwal, Meha Sharma
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
chronic kidney disease
finerenone
meta-analysis
safety
type-2 diabetes
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2022;volume=26;issue=3;spage=198;epage=205;aulast=Dutta

Similar Items

Similar Items